Tarsus Pharmaceuticalsinc Stock Shares Owned By Insiders

TARS Stock  USD 37.32  1.26  3.27%   
Tarsus PharmaceuticalsInc fundamentals help investors to digest information that contributes to Tarsus PharmaceuticalsI's financial success or failures. It also enables traders to predict the movement of Tarsus Stock. The fundamental analysis module provides a way to measure Tarsus PharmaceuticalsI's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tarsus PharmaceuticalsI stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Tarsus PharmaceuticalsInc Company Shares Owned By Insiders Analysis

Tarsus PharmaceuticalsI's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Insiders Shares

 = 

Executives Shares

+

Employees

More About Shares Owned By Insiders | All Equity Analysis

Current Tarsus PharmaceuticalsI Shares Owned By Insiders

    
  8.66 %  
Most of Tarsus PharmaceuticalsI's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tarsus PharmaceuticalsInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Tarsus Shares Owned By Insiders Driver Correlations

Understanding the fundamental principles of building solid financial models for Tarsus PharmaceuticalsI is extremely important. It helps to project a fair market value of Tarsus Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since Tarsus PharmaceuticalsI's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Tarsus PharmaceuticalsI's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Tarsus PharmaceuticalsI's interrelated accounts and indicators.
0.980.98-0.87-0.810.850.650.650.991.01.01.01.00.960.740.82-0.490.61-0.49
0.981.0-0.86-0.750.80.580.491.00.980.980.980.980.960.790.75-0.440.53-0.44
0.981.0-0.85-0.750.80.580.511.00.980.980.980.980.960.760.78-0.410.55-0.41
-0.87-0.86-0.850.77-0.81-0.69-0.56-0.85-0.87-0.87-0.87-0.87-0.89-0.7-0.580.64-0.680.64
-0.81-0.75-0.750.77-0.98-0.97-0.69-0.78-0.8-0.81-0.78-0.81-0.7-0.49-0.890.87-0.930.87
0.850.80.8-0.81-0.980.920.650.820.840.850.830.850.730.650.86-0.840.87-0.84
0.650.580.58-0.69-0.970.920.650.610.650.660.620.660.540.330.8-0.940.97-0.94
0.650.490.51-0.56-0.690.650.650.520.650.660.630.660.550.260.72-0.490.66-0.49
0.991.01.0-0.85-0.780.820.610.520.990.980.980.980.960.770.8-0.460.57-0.46
1.00.980.98-0.87-0.80.840.650.650.991.01.01.00.960.750.82-0.490.6-0.49
1.00.980.98-0.87-0.810.850.660.660.981.01.01.00.960.730.83-0.490.62-0.49
1.00.980.98-0.87-0.780.830.620.630.981.01.01.00.970.760.79-0.470.57-0.47
1.00.980.98-0.87-0.810.850.660.660.981.01.01.00.960.730.83-0.490.62-0.49
0.960.960.96-0.89-0.70.730.540.550.960.960.960.970.960.660.68-0.410.51-0.41
0.740.790.76-0.7-0.490.650.330.260.770.750.730.760.730.660.45-0.290.25-0.29
0.820.750.78-0.58-0.890.860.80.720.80.820.830.790.830.680.45-0.580.79-0.58
-0.49-0.44-0.410.640.87-0.84-0.94-0.49-0.46-0.49-0.49-0.47-0.49-0.41-0.29-0.58-0.881.0
0.610.530.55-0.68-0.930.870.970.660.570.60.620.570.620.510.250.79-0.88-0.88
-0.49-0.44-0.410.640.87-0.84-0.94-0.49-0.46-0.49-0.49-0.47-0.49-0.41-0.29-0.581.0-0.88
Click cells to compare fundamentals
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition

Based on the latest financial disclosure, 8.658% of Tarsus PharmaceuticalsInc are shares owned by insiders. This is 42.96% lower than that of the Pharmaceuticals sector and 38.94% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 14.19% higher than that of the company.

Tarsus Shares Owned By Insiders Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tarsus PharmaceuticalsI's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tarsus PharmaceuticalsI could also be used in its relative valuation, which is a method of valuing Tarsus PharmaceuticalsI by comparing valuation metrics of similar companies.
Tarsus PharmaceuticalsI is currently under evaluation in shares owned by insiders category among related companies.

Tarsus PharmaceuticalsI ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Tarsus PharmaceuticalsI's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Tarsus PharmaceuticalsI's managers, analysts, and investors.
Environmental
Governance
Social

Tarsus Fundamentals

About Tarsus PharmaceuticalsI Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Tarsus PharmaceuticalsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tarsus PharmaceuticalsI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tarsus PharmaceuticalsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Tarsus PharmaceuticalsI

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tarsus PharmaceuticalsI position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus PharmaceuticalsI will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Tarsus PharmaceuticalsI could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tarsus PharmaceuticalsI when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tarsus PharmaceuticalsI - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tarsus PharmaceuticalsInc to buy it.
The correlation of Tarsus PharmaceuticalsI is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tarsus PharmaceuticalsI moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tarsus PharmaceuticalsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tarsus PharmaceuticalsI can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Tarsus PharmaceuticalsInc is a strong investment it is important to analyze Tarsus PharmaceuticalsI's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tarsus PharmaceuticalsI's future performance. For an informed investment choice regarding Tarsus Stock, refer to the following important reports:
Check out Tarsus PharmaceuticalsI Piotroski F Score and Tarsus PharmaceuticalsI Altman Z Score analysis.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Tarsus Stock analysis

When running Tarsus PharmaceuticalsI's price analysis, check to measure Tarsus PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus PharmaceuticalsI is operating at the current time. Most of Tarsus PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Tarsus PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Tarsus PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Is Tarsus PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tarsus PharmaceuticalsI. If investors know Tarsus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tarsus PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.75)
Revenue Per Share
1.35
Quarterly Revenue Growth
10.046
Return On Assets
(0.35)
Return On Equity
(0.66)
The market value of Tarsus PharmaceuticalsInc is measured differently than its book value, which is the value of Tarsus that is recorded on the company's balance sheet. Investors also form their own opinion of Tarsus PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Tarsus PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tarsus PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Tarsus PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tarsus PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tarsus PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tarsus PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.